Literature DB >> 25439644

Evaluating abuse in the patient with dementia.

Pamela Tronetti1.   

Abstract

For patients with dementia, abuse ranges from subtle scams to outright physical violence. As dementia progresses, abuse escalates. The stages of dementia--mild cognitive impairment, mild dementia, moderate dementia, and severe dementia--lend themselves to varied presentations of abuse. Knowing which types of abuse are more prominent at each stage aids the clinician in anticipating risk of abuse and patient and caregiver needs. Interviewing the victim is crucial in uncovering, documenting, and intervening in an abuse situation. A clinician who is skilled in drawing out the facts while remaining supportive of the patient is key in ending the victimization.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; Elder abuse; Interviewing; Victimization

Mesh:

Year:  2014        PMID: 25439644     DOI: 10.1016/j.cger.2014.08.010

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  3 in total

1.  Validation of the Italian Version of the Caregiver Abuse Screen among Family Caregivers of Older People with Alzheimer's Disease.

Authors:  Maria Gabriella Melchiorre; Mirko Di Rosa; Francesco Barbabella; Norma Barbini; Fabrizia Lattanzio; Carlos Chiatti
Journal:  Biomed Res Int       Date:  2017-02-07       Impact factor: 3.411

Review 2.  Neurocognitive mechanisms of theory of mind impairment in neurodegeneration: a transdiagnostic approach.

Authors:  Cherie Strikwerda-Brown; Siddharth Ramanan; Muireann Irish
Journal:  Neuropsychiatr Dis Treat       Date:  2019-02-20       Impact factor: 2.570

3.  Preventing The Abuse Of Residents With Dementia Or Alzheimer's Disease In The Long-Term Care Setting: A Systematic Review.

Authors:  Michael Mileski; Kimberly Lee; Curtis Bourquard; Belinda Cavazos; Kristopher Dusek; Kristopher Kimbrough; Linda Sweeney; Rebecca McClay
Journal:  Clin Interv Aging       Date:  2019-10-22       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.